Mankind Pharma Limited IPO
Mankind Pharma Limited IPO is listed on BSE and NSE, priced at ₹1026–₹1080 per share. The stock debuted at ₹1300, delivering a listing gain of 20.4%. The IPO had a lot size of ₹13 shares and a minimum investment of ₹14,040.
Mankind Pharma Limited IPO
- IPO Dates
- Apr 25, 2023 – Apr 27, 2023
- Price band
- ₹1026-1080 per equity share
- Minimum Investment
- ₹14,040
- Issue size
- 40,058,844 shares(aggregating up to ₹4,326.36 Cr Offer for Sale)
- Lot size
- 13
- Allotment Date
- May 3, 2023
- Listing
- May 9, 2023
- Listing At
- BSE, NSE
IPO timeline
-
Apr 25, 2023
Open Date
Completed
-
Apr 27, 2023
Close Date
Completed
-
May 3, 2023
Allotment Date
Completed
-
May 9, 2023
Listing Date
Completed
Price Summary
- Last closing
- 2,460.00 (127.78%)
- 52 week high
- 2,716.50
- 52 week low
- 1,909.70
- Last update
Mankind Pharma Limited IPO Essentials
Mankind Pharma Limited IPO Details
Mankind Pharma Limited IPO is priced at ₹1026-1080 per share with a total issue size of 40,058,844 shares(aggregating up to ₹4,326.36 Cr Offer for Sale). The IPO has a lot size of 13 shares and is listed on BSE and NSE.
- Issue price
- ₹1026-1080 per equity share
- Lot size
- 13 shares
- Face value
- ₹1 Per Equity Share
- Issue size
- 40,058,844 shares(aggregating up to ₹4,326.36 Cr Offer for Sale)
- Listing at
- BSE, NSE
- List price
- 1300.0(NSE)
- Listing date
- Registrar
- KFin Technologies Limited
- Lead manager
-
Kotak Mahindra Capital Company, Axis Capital Limited, IIFL Securities Ltd, Jefferies India Private Limited, J.P. Morgan India Private Limited
Mankind Pharma Limited IPO Analytics
Mankind Pharma Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Mankind Pharma Limited IPO Subscription Status
Mankind Pharma Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB |
NII
bHNI
sHNI
|
Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 8,011,769 |
6,008,827
4,005,885
2,002,942
|
14,020,596 | 28,041,192 |
|
Day 1
25-04-23 05:00 PM
|
0.08 x |
0.33x
0.37x
0.25x
|
0.10 x | 0.14 x |
|
Day 2
26-04-23 05:00 PM
|
1.86 x |
1.02x
1.21x
0.64x
|
0.25 x | 0.87 x |
|
Day 3
27-04-23 05:00 PM
|
49.16 x |
3.80x
4.99x
1.41x
|
0.92 x | 15.32 x |
Mankind Pharma Limited Valuations
Earnings
- EPS (Post IPO)
- ₹33.2/-
- P/E Ratio
- 32.5
Returns
- RoNW
- 27.7%
Mankind Pharma Limited Financials( In Crs.)
| 31-Dec-22 | 31-Mar-22 | 31-Mar-21 | 31-Mar-20 | |
|---|---|---|---|---|
| Assets | 9,273.75 | 9,147.74 | 6,372.63 | 5,073.29 |
| Revenue | 6,777.82 | 7,977.58 | 6,385.38 | 5,975.65 |
| Profit After Tax | 1,015.98 | 1,452.96 | 1,293.03 | 1,056.15 |
Mankind Pharma Limited Company & Offer Insights
About Mankind Pharma Limited
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations across various acute and chronic therapeutic areas and several consumer healthcare products.
The company has over 36 brands, including Manforce (Rx), Moxikind-CV, Amlokind-AT, Unwanted-Kit, Candiforce, Gudcef, Glimestar-M, Prega News, Dydroboon, Codistar, Nurokind-Gold, Nurokind Plus-RF, Nurokind-LC, Asthakind-DX, Cefakind, Monticope, Telmikind-H, Telmikind, Gudcef-CV, and Unwanted-72, among these.
The company has its presence in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory.
Mankind Pharma has one of the largest distribution networks of medical representatives in the Indian pharmaceutical market (IPM). Over 80% of doctors in India prescribed their formulations and has been ranked number 4th in terms of domestic sales during the Financial Year 2022.
The company has been awarded The Best of Bharat Awards 2022 by exchange4media in the year 2022, Silver Medal from National Awards for Manufacturing Competitiveness Assessment 2021 instituted by International Research Institute for Manufacturing, and Silver Award for Good Health Brand at IHW Awards 2021 in the year 2021, Best Condom Brand of the Year award at Sex Brand Awards Pharma OTC Company of the Year Award at Pharma Excellence Awards 2018, Award for Best Design in Healthcare at Healthcare Leadership Awards 2017, and Amity HR Excellence Award for Performance Management at the 8th Global HR Summit 2011.
Mankind Pharma Limited Promoter(s)
Ramesh Juneja, Rajeev Juneja, Sheetal Arora, Ramesh Juneja Family Trust, Rajeev Juneja Family Trust, Prem Sheetal Family Trust are the company's promoters of Mankind Pharma Limited.
Mankind Pharma Limited IPO Issue Objectives
- •
- All of the offer proceeds will be received by the selling shareholders in proportion to the offered shares that each selling shareholder sold as part of the offer; the company will not receive any of the offer proceeds.
Mankind Pharma Limited IPO - Anchor Investors
Mankind Pharma raises Rs 1,298 crore from anchor investors.
The marquee investors that participated in the offer included Canada Pension Plan, Government of Singapore, Monetary Authority of Singapore, Goldman Sachs, Fiam Group Trust, Blackrock Global Funds, Abu Dhabi Investment Authority, Nomura Funds, Morgan Stanley, and Neuberger Berman Emerging Markets Equity Fund.
Mankind Pharma Limited IPO - Peers Comparison
| P/B Ratio | P/E Ratio | RoNW | Revenue(in Cr.) | |
|---|---|---|---|---|
| Mankind Pharma | 6.05 | 32.5 | 27.7% | 7,977 |
| Sun Pharma | 4.50 | 29.8 | 14.0% | 38,654 |
| Cipla Limited | 3.36 | 27.8 | 13.2% | 21,763 |
| Zydus Lifesciences | 3.14 | 25.1 | 14.7% | 15,265 |
| Torrent Pharma | 8.87 | 43.5 | 18.3% | 8,508 |
| Alkem Lab | 4.37 | 39.0 | 20.7% | 10.634 |
| J B Chemicals & Pharma | 7.10 | 40.4 | 18.1% | 2,424 |
| Eris Lifesciences | 4.16 | 21.4 | 23.4% | 1,347 |
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
Mankind Pharma Limited IPO is a book-built IPO worth ₹40,058,844 shares(aggregating up to ₹4,326.36 Cr Offer for Sale). The price band is ₹1026–₹1080 per share. The IPO opens on Apr 25, 2023 and closes on Apr 27, 2023. It will be listed on BSE and NSE. KFin Technologies Limited is the registrar.
The price band of Mankind Pharma Limited IPO is ₹1026 to ₹1080 per share.
The lot size of Mankind Pharma Limited IPO is 13 shares.
The minimum investment for Mankind Pharma Limited IPO is approximately ₹14,040 based on the upper price band .
Mankind Pharma Limited IPO opens on Apr 25, 2023 and closes on Apr 27, 2023.
The allotment date of Mankind Pharma Limited IPO is May 3, 2023.
Mankind Pharma Limited IPO is expected to be listed on May 9, 2023, on BSE and NSE .
Mankind Pharma Limited IPO listed on May 9, 2023. It was issued at ₹1300.0(NSE) and is currently around ₹2460.00 as on 14-May-2026 3:30 PM, which is approximately 127.8% versus issue price. The 52-week high is ₹2,716.50.
Based on listing and post-listing performance, Mankind Pharma Limited IPO delivered around 127.8% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.
To buy Mankind Pharma Limited IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.
Mankind Pharma Limited IPO valuation snapshot: P/E 32.5, EPS ₹33.2/-, P/B N/A, RoNW 27.7%, and market cap N/A.
To apply for Mankind Pharma Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Mankind Pharma Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Mankind Pharma Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Mankind Pharma Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Mankind Pharma Limited IPO allotment status on IPO Ji for quick and easy access.